Page last updated: 2024-08-25

methotrexate and Hyperpigmentation

methotrexate has been researched along with Hyperpigmentation in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's1 (11.11)29.6817
2010's2 (22.22)24.3611
2020's5 (55.56)2.80

Authors

AuthorsStudies
Agarwal, A; Kumar, A; Sharma, A1
Panda, PK; Sharawat, IK; Yadav, R1
Abbaszadeh, M; Shafie, M; Sharifi, F1
Alfagemeb, F; Laverde-Saad, A; Lopez-Negrete, E; Roustan, G1
Hsu, T; Lee, LW; Lu, MC; Shyur, SD1
Abdelhak, S; Chamli, A; Fenniche, S; Hammami, H; Jaouadi, H; Jouini, R; Zaouak, A1
Ellis, D; Necessary, CA; Roffwarg, D1
Adami, F; Briani, C; Marcolongo, R; Pavan, A; Rondinone, R; Scarlato, M1
Al-Lamki, Z; Jaffe, N; Pearson, P1

Other Studies

9 other study(ies) available for methotrexate and Hyperpigmentation

ArticleYear
'Oil-drop' pigmentation in psoriatic arthritis.
    Postgraduate medical journal, 2020, Volume: 96, Issue:1133

    Topics: Ankle Joint; Antirheumatic Agents; Arthralgia; Arthritis, Psoriatic; Disease Progression; Edema; Etanercept; Humans; Hyperpigmentation; Knee Joint; Male; Methotrexate; Middle Aged; Nail Diseases; Nails

2020
Methotrexate-Induced Hyperpigmentation Over Sun-Exposed Area.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2021, Oct-01, Volume: 27, Issue:7

    Topics: Humans; Hyperpigmentation; Methotrexate

2021
Hyperpigmentation, severe alopecia, and six days of instability in a case of severe methotrexate hypersensitivity reaction.
    Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 2021, Volume: 29, Issue:1

    Topics: Abortifacient Agents, Nonsteroidal; Adult; Alopecia; Anti-Bacterial Agents; Drug Hypersensitivity; Erythropoietin; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Hyperpigmentation; Meropenem; Methotrexate; Pancytopenia; Platelet Transfusion; Pregnancy; Pregnancy, Ectopic; Pseudomonas aeruginosa; Pseudomonas Infections; Unconsciousness

2021
Dermatologic ultrasound in the management of childhood linear morphea.
    Dermatology online journal, 2021, Jul-15, Volume: 27, Issue:7

    Topics: Arm; Biopsy; Child; Dermatologic Agents; Disease Progression; Female; Humans; Hyperpigmentation; Methotrexate; Scleroderma, Localized; Skin; Subcutaneous Tissue; Ultrasonography; Ultrasonography, Interventional

2021
Unilateral generalized morphea: First case report in Taiwan.
    Asian Pacific journal of allergy and immunology, 2020, Volume: 38, Issue:2

    Topics: Administration, Oral; Administration, Topical; Child; Emollients; Female; Humans; Hyperpigmentation; Methotrexate; Penicillamine; Prednisolone; Scleroderma, Localized; Skin; Taiwan; Treatment Outcome

2020
H-like syndrome successfully treated with methotrexate.
    Dermatologic therapy, 2019, Volume: 32, Issue:4

    Topics: Adult; Dermatologic Agents; Female; Humans; Hyperpigmentation; Methotrexate; Skin Diseases; Syndrome

2019
Reticulated hyperpigmentation following chemotherapy for radiation-induced osteosarcoma.
    Journal of the American Academy of Dermatology, 2014, Volume: 71, Issue:1

    Topics: Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Eruptions; Etoposide; Humans; Hyperpigmentation; Ifosfamide; Male; Methotrexate; Middle Aged; Neoplasms, Radiation-Induced; Orbital Neoplasms; Osteosarcoma; Triamcinolone

2014
Polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes: not always a POEMS syndrome.
    Haematologica, 2006, Volume: 91, Issue:5 Suppl

    Topics: Cyclosporine; Diagnostic Errors; Eosinophilia; Fasciitis; Hepatomegaly; Humans; Hyperpigmentation; Immunoglobulin G; Immunoglobulin lambda-Chains; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Paresthesia; Peripheral Nervous System Diseases; POEMS Syndrome; Prednisone; Reflex, Abnormal; Skin; Vascular Endothelial Growth Factor A

2006
Localized cisplatin hyperpigmentation induced by pressure. A case report.
    Cancer, 1996, Apr-15, Volume: 77, Issue:8

    Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Doxorubicin; Humans; Hyperpigmentation; Male; Methotrexate; Osteosarcoma; Pressure

1996